Investing for the long term takes patience and discipline to stay the course. It’s not necessarily easy, but the payoff can be significant. Right now, a lot of the hype is around Nvidia and other tech stocks involved with artificial intelligence, but many of those stocks are already trading at exceptionally high valuations. For investors, that means there may not be much more upside available.
Instead, there’s another compelling option to consider that’s outside of tech, and that may be a more intriguing opportunity for growth investors: cannabis.
Will AI create the world’s first trillionaire? Our team just released a report on the one little-known company, called an “Indispensable Monopoly” providing the critical technology Nvidia and Intel both need. Continue »
The cannabis market could take off over the next several years
The U.S. hasn’t legalized cannabis, but it has recently rescheduled FDA-approved marijuana products from Schedule I to Schedule III, which is a huge milestone for the industry. More reform could be coming, and the hope is that this could be the first step toward potentially legalization in the future. That’s not on the horizon just yet, and there’s no guarantee what will happen in the future, but the government does appear to be considering the benefits of marijuana, which is an encouraging sign.
According to estimates from Fortune Business Insights, the global cannabis market could be worth more than $1.4 trillion by 2034, up from just under $138 billion this year. This assumes greater legalization and access to medical and recreational products, and it highlights the significant potential for growth as this translates into a compounded annual growth rate of more than 34%.
Investing in cannabis stocks comes with risk, but the payoff could be huge
One of the most popular cannabis stocks to invest in is Tilray Brands (NASDAQ: TLRY), a Canadian-based company that has long been eyeing opportunities in the U.S. market. It has even expanded into U.S. craft brewers as a way to expand its presence in the U.S. without having to rely on marijuana legalization.
Tilray is not necessarily the safest cannabis stock to own, as it routinely incurs losses and continues to burn through cash. But when there is talk of legalization, or there are hopes of reform in the U.S., it often surges in value. There are also multi-state operators to consider, such as Curaleaf Holdings and Trulieve Cannabis, which may more directly benefit from marijuana rescheduling in the U.S.